Two-step targeting of urokinase to plasma clot provides efficient fibrinolysis
- 1 March 1988
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 49 (5) , 481-488
- https://doi.org/10.1016/s0049-3848(98)90005-6
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- On the possibility of the unification of drug targeting systemsBiochemical Pharmacology, 1987
- Thrombolytic therapy in the eightiesBlood, 1986
- Single-chain urokinase-type plasminogen activators: New hopes for clot-specific lysisEuropean Heart Journal, 1985
- Antibody-Directed Urokinase: A Specific Fibrinolytic AgentScience, 1985
- Water-soluble urokinase derivatives with increased affinity to the fibrin clotThrombosis Research, 1985
- Cerebrovascular complications of streptokinase infusionPublished by American Medical Association (AMA) ,1985
- Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology.Circulation, 1984
- Specificity of a monoclonal antibody for the NH2-terminal region of fibrinMolecular Immunology, 1984
- Monoclonal Antibodies to a Synthetic Fibrin-Like Peptide Bind to Human Fibrin But Not FibrinogenScience, 1983
- Streptokinase and Urokinase in the Treatment of Pulmonary ThromboemboliThrombosis and Haemostasis, 1976